Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 5/20 | 0.52 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.50 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.48 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.48 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.44 |
| ▸ | NADK | O95544 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17446882 | 0.93 | AHCY (0.52) | AHCYEHMT1PRMT5WDR77HSP90B1 | |
| SCHEMBL17641471 | 0.85 | AHCY (0.51) | AHCYEHMT1PRMT5WDR77HSP90B1 | |
| SCHEMBL17000652 | 0.84 | AHCY (0.51) | AHCYEHMT1PRMT5WDR77HSP90B1 | |
| SCHEMBL17446883 | 0.82 | PRMT6 (0.42) | — | |
| SCHEMBL19221820 | 0.82 | AHCY (0.53) | AHCYPRMT5WDR77ADORA3ADORA2B | |
| SCHEMBL11985295 | 0.80 | AHCY (0.50) | AHCYEHMT1HSP90B1ADORA3ADORA2B | |
| SCHEMBL19221822 | 0.78 | AHCY (0.53) | AHCYPRMT5WDR77ADORA3ADORA2B | |
| SCHEMBL14303665 | 0.78 | AHCY (0.49) | AHCYEHMT1ADORA3ADORA2B | |
| SCHEMBL15267255 | 0.78 | AHCY (0.51) | AHCYEHMT1HSP90B1ADORA3ADORA2B | |
| SCHEMBL11985323 | 0.78 | AHCY (0.51) | AHCYEHMT1HSP90B1ADORA3ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9725474-B2 | Modified nucleic acid | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2017-08-08 | — | — | US | disclosed |